Banco De Sabadell, S.A Age X Therapeutics, Inc. Transaction History

Banco De Sabadell, S.A

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$0.79 - $1.52 $1,580 - $3,040	-2,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$0.78 - $1.95 $1,560 - $3,900	2,000 New	2,000 $2,000
Q4 2019 Feb 14, 2020	SELL	$1.25 - $1.82 $2,500 - $3,640	-2,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.49 - $5.5 $4,980 - $11,000	2,000 New	2,000 $6,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

Stay updated on Banco De Sabadell, S.A with notifications on news.